Author Correction: Spread of pathological tau proteins through communicating neurons in human Alzheimer’s disease

Código QR

Author Correction: Spread of pathological tau proteins through communicating neurons in human Alzheimer’s disease

Guardado en:

Detalles Bibliográficos
Autores principales:	Jacob W. Vogel, Yasser Iturria-Medina, Olof T. Strandberg, Ruben Smith, Elizabeth Levitis, Alan C. Evans, Oskar Hansson, Alzheimer’s Disease Neuroimaging Initiative, the Swedish BioFinder Study
Formato:	article
Lenguaje:	EN
Publicado:	Nature Portfolio 2021
Materias:	Science Q
Acceso en línea:	https://doaj.org/article/765a99c65623442bb627529263d7843d
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Spread of pathological tau proteins through communicating neurons in human Alzheimer's disease
por: Jacob W. Vogel, et al.
Publicado: (2020)

Functional brain architecture is associated with the rate of tau accumulation in Alzheimer’s disease
por: Nicolai Franzmeier, et al.
Publicado: (2020)

Basal forebrain degeneration precedes and predicts the cortical spread of Alzheimer’s pathology
por: Taylor W. Schmitz, et al.
Publicado: (2016)

The BIN1 rs744373 SNP is associated with increased tau-PET levels and impaired memory
por: Nicolai Franzmeier, et al.
Publicado: (2019)

Plasma phosphorylated-tau181 as a predictive biomarker for Alzheimer’s amyloid, tau and FDG PET status
por: Xue-Ning Shen, et al.
Publicado: (2021)

Identification of Disease-Related Genes That Are Common between Alzheimer’s and Cardiovascular Disease Using Blood Genome-Wide Transcriptome Analysis
por: Taesic Lee, et al.
Publicado: (2021)

Correlation between Alzheimer’s disease and type 2 diabetes using non-negative matrix factorization
por: Yeonwoo Chung, et al.
Publicado: (2021)

KL-VS heterozygosity is associated with lower amyloid-dependent tau accumulation and memory impairment in Alzheimer’s disease
por: Julia Neitzel, et al.
Publicado: (2021)

Cascaded Multi-view Canonical Correlation (CaMCCo) for Early Diagnosis of Alzheimer’s Disease via Fusion of Clinical, Imaging and Omic Features
por: Asha Singanamalli, et al.
Publicado: (2017)

Prevalence of Alzheimer's pathologic endophenotypes in asymptomatic and mildly impaired first-degree relatives.
por: Erika J Lampert, et al.
Publicado: (2013)

Early role of vascular dysregulation on late-onset Alzheimer’s disease based on multifactorial data-driven analysis
por: Y. Iturria-Medina, et al.
Publicado: (2016)

Mild behavioral impairment correlates of cognitive impairments in older adults without dementia: mediation by amyloid pathology
por: Yan Sun, et al.
Publicado: (2021)

Network propagation of rare variants in Alzheimer's disease reveals tissue-specific hub genes and communities.
por: Marzia Antonella Scelsi, et al.
Publicado: (2021)

Aspirin using was associated with slower cognitive decline in patients with Alzheimer's disease.
por: Jinyan Weng, et al.
Publicado: (2021)

Glucose metabolism during resting state reveals abnormal brain networks organization in the Alzheimer's disease and mild cognitive impairment.
por: Gretel Sanabria-Diaz, et al.
Publicado: (2013)

Predicting future clinical changes of MCI patients using longitudinal and multimodal biomarkers.
por: Daoqiang Zhang, et al.
Publicado: (2012)

Higher CSF sTNFR1-related proteins associate with better prognosis in very early Alzheimer’s disease
por: William T. Hu, et al.
Publicado: (2021)

Imaging tau pathology in Parkinsonisms
por: Sarah Coakeley, et al.
Publicado: (2017)

Association of a Total Cholesterol Polygenic Score with Cholesterol Levels and Pathological Biomarkers across the Alzheimer’s Disease Spectrum
por: Nathalie I. V. Nilsson, et al.
Publicado: (2021)

aBEAT: a toolbox for consistent analysis of longitudinal adult brain MRI.
por: Yakang Dai, et al.
Publicado: (2013)

Ubiquilin 2 is not associated with tau pathology.
por: Anna Nölle, et al.
Publicado: (2013)

Acetylated tau inhibits chaperone-mediated autophagy and promotes tau pathology propagation in mice
por: Benjamin Caballero, et al.
Publicado: (2021)

Pairwise Correlation Analysis of the Alzheimer’s Disease Neuroimaging Initiative (ADNI) Dataset Reveals Significant Feature Correlation
por: Erik D. Huckvale, et al.
Publicado: (2021)

The role of pathological tau in synaptic dysfunction in Alzheimer’s diseases
por: Moxin Wu, et al.
Publicado: (2021)

Accelerated inflammatory aging in Alzheimer’s disease and its relation to amyloid, tau, and cognition
por: Nicholas C. Cullen, et al.
Publicado: (2021)

To target Tau pathologies, we must embrace and reconstruct their complexities
por: Galina Limorenko, et al.
Publicado: (2021)

Hierarchical interactions model for predicting Mild Cognitive Impairment (MCI) to Alzheimer's Disease (AD) conversion.
por: Han Li, et al.
Publicado: (2014)

A longitudinal study of atrophy in amnestic mild cognitive impairment and normal aging revealed by cortical thickness.
por: Zhijun Yao, et al.
Publicado: (2012)

Using manifold learning for atlas selection in multi-atlas segmentation.
por: Albert K Hoang Duc, et al.
Publicado: (2013)

APOE ε2 is associated with increased tau pathology in primary tauopathy
por: Na Zhao, et al.
Publicado: (2018)

Boosting the diagnostic power of amyloid-β PET using a data-driven spatially informed classifier for decision support
por: Ashwin V. Venkataraman, et al.
Publicado: (2021)

A Computational Model of the Trans-Synaptic Spread of Pathogenic Tau in Early Alzheimer’s Disease
por: Bashir Sbaiti, et al.
Publicado: (2021)

The neuritic plaque facilitates pathological conversion of tau in an Alzheimer’s disease mouse model
por: Tong Li, et al.
Publicado: (2016)

Human Induced Pluripotent Stem Cell Models of Frontotemporal Dementia With Tau Pathology
por: Rebekka Kühn, et al.
Publicado: (2021)

Information Flow Pattern in Early Mild Cognitive Impairment Patients
por: Haijuan He, et al.
Publicado: (2021)

Relationship between plasma analytes and SPARE-AD defined brain atrophy patterns in ADNI.
por: Jon B Toledo, et al.
Publicado: (2013)

Characterizing the role of brain derived neurotrophic factor genetic variation in Alzheimer's disease neurodegeneration.
por: Robyn A Honea, et al.
Publicado: (2013)

Cerebrospinal fluid p-tau217 performs better than p-tau181 as a biomarker of Alzheimer’s disease
por: Shorena Janelidze, et al.
Publicado: (2020)

Federated Morphometry Feature Selection for Hippocampal Morphometry Associated Beta-Amyloid and Tau Pathology
por: Jianfeng Wu, et al.
Publicado: (2021)

MAPT R406W increases tau T217 phosphorylation in absence of amyloid pathology
por: Chihiro Sato, et al.
Publicado: (2021)